Evidence map›Paper›PMID 39839029›Full record

ArticleQuantitative imaging in medicine and surgery2025

Development and validation of a multi-parametric MRI deep-learning model for preoperative lymphovascular invasion evaluation in rectal cancer.

Shengming Shi, Apekshya Singh, Jiaqi Ma, Xinsheng Nie, Xiangjiang Kong, Lingqing Xiao, Han Liu, Yupeng Wu, Xiaofu Li

Abstract read
In one paragraph

Article in Quantitative imaging in medicine and surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Shengming ShiDepartment of Magnetic Resonance Imaging Diagnostic, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Apekshya SinghDepartment of Magnetic Resonance Imaging Diagnostic, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Jiaqi MaDepartment of Magnetic Resonance Imaging Diagnostic, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Xinsheng NieMedical Imaging Center, Xinjiang Production and Construction Corps Tenth Division Beitun Hospital, Beitun, China.
Xiangjiang KongMedical Imaging Center, Xinjiang Production and Construction Corps Tenth Division Beitun Hospital, Beitun, China.
Lingqing XiaoMedical Imaging Center, Xinjiang Production and Construction Corps Tenth Division Beitun Hospital, Beitun, China.
Han LiuDepartment of Magnetic Resonance Imaging Diagnostic, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Yupeng WuDepartment of Magnetic Resonance Imaging Diagnostic, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.
Xiaofu LiDepartment of Magnetic Resonance Imaging Diagnostic, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Lymphovascular invasion (LVI) is an independent prognostic factor for patients with rectal cancer (RC). Recent studies have shown that deep learning (DL)-based magnetic resonance imaging (MRI) has potential in evaluating the treatment response of RC patients, but the role of MRI-based DL in assessing RC LVI remains unclear. This study sought to develop and validate a DL model to evaluate the LVI status of RC patients preoperatively based on MRI, and to test its performance at an external center. Methods: The data of 489 patients with surgically confirmed RC were retrospectively collected from two centers. The training set and the internal validation set comprised 320 patients and 80 patients, respectively, from The Second Affiliated Hospital of Harbin Medical University; while the external testing set comprised 89 patients from Xinjiang Production and Construction Corps Tenth Division Beitun Hospital. All the patients underwent MRI examinations before surgery. Two separate image models were constructed based on the three-dimensional (3D) residual network (ResNet)-18 architecture, using only T2-weighted image (T2WI) data and diffusion-weighted image (DWI) data, respectively, to assess LVI, and a combined model was developed that integrated T2WI, DWI, and clinical factors to assess LVI. The performance of the T2WI- and DWI-based models, and the combination model was evaluated using the area under the curve (AUC) and the DeLong test. The clinical utility of these models was assessed by calibration curve analysis and decision curve analysis (DCA). Results: The T2WI- and DWI-based DL models demonstrated robust capabilities in evaluating LVI in RC in both the internal validation set and the external test set. For the T2WI-based model, the AUC values reached 0.795 and 0.764 in the internal validation set and the external test set, respectively. For the DWI-based model, the AUC values reached 0.822 and 0.825 in the internal validation set and the external test set, respectively. The combined model exhibited superior performance, achieving AUC values of 0.899 and 0.848 in the internal validation set and the external test set, respectively. In the external test set, all three DL models exhibited robust calibration. The DCA also showed that the DWI-based model and the combined model offered a significantly greater overall net benefit in evaluating LVI than the T2WI-based model. Conclusions: The multi-parametric MRI DL model demonstrated excellent performance in evaluating the LVI status of patients with RC. This model could serve as a complementary method for the non-invasive assessment of LVI in RC.

Indexed as

deep learning (DL)lymphovascular invasion (LVI)magnetic resonance imaging (MRI)non-invasive evaluationRectal cancer (RC)

Identifiers

PMID39839029
PMCPMC11744136

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.